GS

Goldy Singh

Active Director Director DIN 08777508
DIN 08777508 First appointment Jul 2020 Primary industry Food And Beverages
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2020
Shareholding value •••• Premium profile

About Goldy Singh

Data last updated:

Goldy Singh is a Director at Starcia Pharmaceuticals Private Limited (since 2020). The company operates in Food And Beverages. Starcia Pharmaceuticals Private Limited reported revenue of ₹5.3 Lakh (FY 2025).

DIN 08777508
Primary Designation Director
Industry Food And Beverages
First Appointment 07 Jul 2020
Oldest Company Age 6 yrs
Largest company Starcia Pharmaceuticals Private Limited · ₹5.3 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director07 Jul 20202020₹5.3 Lakh (FY 2025)Active

Board colleagues of Goldy Singh

Directorship timeline

Open interactive timeline →
Starcia Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Goldy Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Goldy Singh

Goldy Singh currently holds 1 directorship: Starcia Pharmaceuticals Private Limited (Director, since 07 Jul 2020, revenue ₹5.3 Lakh (FY 2025)).

Goldy Singh was first appointed on 07 Jul 2020 as Director at Starcia Pharmaceuticals Private Limited.

The current boards of Goldy Singh's companies include Manish Singh (Starcia Pharmaceuticals Private Limited), Nibha Singh (Starcia Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available